ANNA COMSTOCK: Open Payments
NPI 1508407131 · SHELBYVILLE, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$741 in 46 payments from 14 companies in 2025. Trend: 2023 $842 · 2024 $792 · 2025 $741
Food & beverage: $741
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 14 | $183 |
| Novo Nordisk Inc | 11 | $148 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $61 |
| Axsome Therapeutics, Inc. | 3 | $59 |
| Regeneron Healthcare Solutions, Inc. | 3 | $56 |
| Lilly USA, LLC | 2 | $55 |
| Astellas Pharma US Inc | 2 | $35 |
| Insulet Corporation | 1 | $30 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Alkermes, Inc. | 1 | $26 |
Products named: VRAYLAR, JARDIANCE, Auvelity, EVKEEZA, Ozempic, Veozah, OMNIPOD, CAPLYTA.
Industry payments across IN — which companies pay providers there.
